These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7118290)

  • 21. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hemodialysis on leukocyte adhesion receptor expression.
    Kaupke CJ; Zhang J; Cesario T; Yousefi S; Akeel N; Vaziri ND
    Am J Kidney Dis; 1996 Feb; 27(2):244-52. PubMed ID: 8659501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane selection for renal replacement therapy: a mountain or molehill?
    Farrell PC; Odell RA
    Contrib Nephrol; 1985; 44():97-111. PubMed ID: 3886286
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellulose acetate hemodialysis membranes are better tolerated than Cuprophan. A difference in complement and neutrophil activation.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Contrib Nephrol; 1984; 37():78-82. PubMed ID: 6713881
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukotriene release from neutrophils of patients on hemodialysis with cellulose membranes.
    Jörres A; Jörres D; Gahl GM; Schulz E; Mahiout A
    Int J Artif Organs; 1992 Feb; 15(2):84-8. PubMed ID: 1313396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
    Losito A; Buoncristiani U; Cecchini C
    J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of leukotriene B4 by hemodialyzer membranes: a novel index of biocompatibility.
    Strasser T; Schiffl H
    Klin Wochenschr; 1991 Oct; 69(17):808-12. PubMed ID: 1662325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 32. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 33. Biocompatibility of a polycarbonate membrane. A preliminary report.
    De Broe ME; van Waeleghem JP; Heyrman R; De Backer W
    Blood Purif; 1986; 4(1-3):168-71. PubMed ID: 3015165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical use of a new hydrate cellulose membrane for hemodialysis].
    Baeva LB; Levitskiĭ ER; Poddubnaia LP; Makhortov NS; Zaĭtsev VG
    Ter Arkh; 1983; 55(6):98-100. PubMed ID: 6612628
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiopulmonary effects of cuprophane-activated plasma in the swine.
    Cheung AK; LeWinter M; Chenoweth DE; Lew WY; Henderson LW
    Kidney Int; 1986 Apr; 29(4):799-806. PubMed ID: 3086612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation and neutrophil aggregation changes during haemodialysis.
    Kubatiev A; Rudko I; Ermolenko V
    Int J Clin Pharmacol Res; 1993; 13(6):293-9. PubMed ID: 8088929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction between blood and dialysis membrane].
    Szepietowski T; Orłowski A
    Polim Med; 1991; 21(3-4):3-13. PubMed ID: 1822594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the dialysis membrane on mortality of chronic hemodialysis patients.
    Hakim RM; Held PJ; Stannard DC; Wolfe RA; Port FK; Daugirdas JT; Agodoa L
    Kidney Int; 1996 Aug; 50(2):566-70. PubMed ID: 8840287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum transcortin levels in patients with chronic hemodialysis.
    De Moor P; Faict D; Verberckmoes R
    Ann Biol Clin (Paris); 1985; 43(3):267-9. PubMed ID: 3927790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.